FindTrial
Sign In

Impact of 68Ga-FAPI-04 positron emission tomography/computed tomography (PET/CT) on staging and treatment in patients with gastric cancer

Impact of 68Ga-FAPI-04 positron emission tomography/computed tomography (PET/CT) on staging and treatment in patients with gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090068
Enrollment
Unknown
Registered
2024-09-23
Start date
2024-05-11
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Case series:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
24 Years to 83 Years

Inclusion criteria

Inclusion criteria: 1) age 18 years or older 2) sufficient GSI data available; 3) less than 30 days between the enhanced CT examination and and 68Ga-FAPI-04 PET/CT, 4) no interventions or treatments between undergoing the enhanced CT examination and and 68Ga-FAPI-04 PET/CT; 5) sufficient follow-up (at least 6 months) to determine clinical Results.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Clinical staging;—

Secondary

MeasureTime frame
Treatment management;—

Countries

China

Contacts

Public ContactHongfeng Gou

West China Hospital, Sichuan University

gouhongfeng1977@wchscu.cn+86 189 8060 2292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026